Literature DB >> 1358587

Benzodiazepine use and HIV risk-taking behaviour among injecting drug users.

S Darke1, W Hall, M Ross, A Wodak.   

Abstract

This paper examines the prevalence of benzodiazepine use, and its relationship to other drug use and HIV risk-taking among a sample of 1245 injecting drug users (IDU). Approximately a third (36.6%) of the sample had used benzodiazepines during their last typical month of injecting. Benzodiazepine users had injected more frequently, injected more heroin and amphetamines, and had more poly-drug use than other IDU. They also had higher levels of HIV risk-taking, having shared injecting equipment more frequently and with more people. There were no differences between groups in number of sexual partners or condom use, although benzodiazepine users were more likely to have been paid for sex. The demographic and drug use variables indicate that benzodiazepine users are a more dysfunctional subgroup of IDU who require particular attention in HIV interventions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358587     DOI: 10.1016/0376-8716(92)90005-w

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  15 in total

1.  Methadone programmes. The costs and benefits to society and the individual.

Authors:  G E Ralston; P Wilson
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

2.  Supporting problem drug users: improving methadone maintenance in general practice.

Authors:  P Wilson; R Watson; G E Ralston
Journal:  Br J Gen Pract       Date:  1995-09       Impact factor: 5.386

3.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

4.  Co-abuse of opiates and benzodiazepines.

Authors:  S Rooney; G Kelly; L Bamford; D Sloan; J J O'Connor
Journal:  Ir J Med Sci       Date:  1999 Jan-Mar       Impact factor: 1.568

5.  Acute effects of alprazolam on risky decision making in humans.

Authors:  Scott D Lane; Oleg V Tcheremissine; Lori M Lieving; Sylvain Nouvion; Don R Cherek
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

Review 6.  Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention.

Authors:  B C Leigh; R Stall
Journal:  Am Psychol       Date:  1993-10

Review 7.  Methadone maintenance treatment in opiate dependence: a review.

Authors:  M Farrell; J Ward; R Mattick; W Hall; G V Stimson; D des Jarlais; M Gossop; J Strang
Journal:  BMJ       Date:  1994-10-15

8.  Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study).

Authors:  Jennifer L Evans; Judith A Hahn; Paula J Lum; Ellen S Stein; Kimberly Page
Journal:  Drug Alcohol Depend       Date:  2009-01-31       Impact factor: 4.492

9.  Modulation of human risky decision making by flunitrazepam.

Authors:  Scott D Lane; Don R Cherek; Sylvain O Nouvion
Journal:  Psychopharmacology (Berl)       Date:  2007-10-05       Impact factor: 4.530

10.  Self-report of illicit benzodiazepine use on the Addiction Severity Index predicts treatment outcome.

Authors:  Udi E Ghitza; David H Epstein; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2008-05-21       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.